Paweł Kapelski Selected Research

Paweł Kapelski Research Topics

9	Schizophrenia (Dementia Praecox) 01/2022 - 01/2002
5	Bipolar Disorder (Manic Depressive Psychosis) 11/2021 - 01/2002
2	Mood Disorders (Mood Disorder) 01/2008 - 01/2002
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Rheumatoid Arthritis 12/2021
1	Morphine Dependence 12/2021
1	Tobacco Use Disorder (Nicotine Dependence) 12/2021
1	Diabetes Mellitus 12/2021
1	Depressive Disorder (Melancholia) 01/2021
1	Inflammation (Inflammations) 01/2016
1	Psychotic Disorders (Schizoaffective Disorder) 01/2006

3	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2021
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 03/2010 - 09/2006
1	CytokinesIBA 01/2022
1	InterleukinsIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	CalciumIBA 12/2021
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 12/2021
1	Pharmaceutical PreparationsIBA 12/2021
1	EndocannabinoidsIBA 12/2021
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	MelatoninIBA 01/2021
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2016
1	Antipsychotic Agents (Antipsychotics)IBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2008
1	Glycogen Synthase (Synthase I)IBA 01/2006
1	Glycogen Synthase Kinase 3 betaIBA 01/2006
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2005
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 05/2002
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2002
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2002
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2002

1	Therapeutics 01/2016